Autoantibodies in autoimmune connective tissue diseases. Actas dermosifiliogr 1999;90:L-7;Autoanticuerpos en las enfermedades autoinmunes del tejido conectivo

Actas Dermo-Sifiliograficas

Volumn 90, Issue 1-2, 1999, Pages 1-7

  Garde, José Barrio ^a   López Longo, Francisco Javier ^a   Hermosa, José Manuel Hernanz ^a  

^a NONE

Author keywords

Antineutrophil cytoplasmic antibodies (anca); Antinuclear antibodies (ana); Antiphospholipid antibodies; Autoantibodies; Connective tissue diseases

Indexed keywords

EID: 0043264880     PISSN: 00017310     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Tan EM. Systemic lupus erythematosus: immunological aspects. En: McCarty DJ, ed. Arthritis and allied conditions. Filadelfia: Lea and Febiger; 1989. p. 1049-54.
2. Meyer O. Antinuclear antibodies. Rheumatology in Europe 1994;23:108-11.
3. López-Longo FJ, Rodríguez M, Grau R, Carreño L. Autoanticuerpos en las enfermedades reumáticas. Clasificación y técnicas de detección. Rev Esp Reumatol 1996;23:343-9.
4. Fariñas MC. Autoanticuerpos en el lupus eritematoso sistémico. Med Clin (Barc) 1993;100:98-100.
5. Venables PJW. Polymyositis-associated overlap syndromes. Br J Rheumatol 1996;35:305-6.
6. Marguerie C. Bunn CC, Copier J y cols. The clinical and immunogenetic features of patients with antibodies to the nucleolar antigen PM-Scl. Medicine 1992;71:327-36.
7. Koffler D, Miller TE, Faifermaii I. Antipolynucleotide antibodies: the rheumatic connection. Human Pathol 1983;14:406-18.
8. Rodríguez M, Sánchez E, González GM, López-Longo FJ. Anticuerpos anti-ADN y dirigidos contra proteínas asociadas al ADN. Rev Esp Reumatol 1996;23:375-83.
9. Tan EM. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989;44:93-151.
10. Petterson I, Hinterberger M, Mimori T, Gottlieb E. Steitz JA. The structure of mammalian small nuclear ribonucleoproteins: identification of multiple protein components reactive with anti-(U1) RNP and anti-Sm antibodies. J Biol Chem 1984;259;5907-14.
11. Field M, Williams DG, Charles P. Maini RN. Specificity of anti-Sm antibodies by ELISA for systemic lupus erythematosus: increased sensivitiy of detection using purified peptide antigens. Ann Rheum Dis 1988;47:820-5.
12. López-Longo FJ, González GM, Monteagudo I. Aiiticuerpos anti-U1 RNP y anti-Sm. Rev Esp Reumatol 1996;23:369-74.
13. Vlachoyiannopoulos PG, Guialis A, Tzioufas AG, Moutsopoulos HM. Predominance of IgM anti-U1 RNP antibodies in patients with systemic lupus erythematosus. Br J Rheumatol 1996;35:534-41.
14. Craft J. Antibodies to snRNPs in systemic lupus erythematosus. Rheum Dis Clin North Am 1992;18:311-35.
15. Provost TT, Watson R, Simmons-O'Brien E. Significance of the anti-Ro (SS-A) antibody in evaluation of patients with cutaneuos manifestations of a connective tissue disease. J Am Acad Dermatol 1996;35:147-69.
16. Bielsa I. Anticuerpos antinucleares y citoplásmicos. Significado clínico y biológico. Piel 1995;10:445-8.
17. Lerner MR, Boyle JA, Hardin JA y cols. Two novel classes of small RNA proteins detected by antibodies associated with lupus erythematosus. Science 1981;211:400-2.
18. Itoh K, Itoh Y, Frank MB. Protein heterogeneity in the human Ro/SSA ribonucleoproteins. The 52 and 60 kD Ro/SSA autoantigens are encoded by separate genes. J Clin Invest 1991;87:177-86.
19. Buyon JP, Ben-Chetrit E, Karp S y cols. Acquired congenital heart block. Pattern of maternal antibody responses to biochemically defined antigens of the SSA/Ro-SSB/La system in neonatal lupus. J Clin Invest 1989;84:627-34.
20. McCauliffe DP, Sontheimer RD. Molecular characterization of the Ro/SS-A autoantigens. J Invest Dermatol 1993;100:73S-79S.
21. Maddison PJ, Lee L, Reichlin M y cols. Anti-p57: a novel association with neonatal lupus. Clin Exp Immunol 1995;99:42-8.
22. López-Longo FJ, Moreno AC, González CM. Anticuerpos anti-Ro/SS-A y ant-La/SS-B. Rev Esp Reumatol 1996;23:362-8.
23. Watson RM, Talwar P, Alexander E y cols. Subacute cutaneous lupus erythematosus: immunogenetic associations. J Autoimmun 1991;4:73-85.
24. Maddison PJ, Provost TT, Reichlin M. Serological findings in patients with «ANA-negative» systemic lupus erythematosus. Medicine (Baltimore) 1981;60:87-94.
25. Provost TT, Arnett FC, Reichlin M. Homozygous C2-Deficiency, lupus erythematosus and anti-Ro/SS-A antibodies. Arthritis Rheum 1983;26:1279-82.
26. Watson RM, Lane AT, Barrett NK, Bias WB, Arnett FC, Provost TT. Neonatal lupus erythematosus: a clinical, serological and immunogenetic study with review of the literature. Medicine (Baltimore) 1984;63:362-78.
27. Carreño L, Rodríguez M. Mecanismos inmunopatogénicos de los autoanticuerpos. Rev Esp Reumatol 1996;23:357-61.
28. Zappi E, Sontheimer R. Clinical relevance of antibodies to Ro/SS-A and La/SS-B in subacute cutaneous lupus erythematosus and related conditions. Clinics in Dermatology 1993;10:431-41.
29. Lee LA, Roberts CM, Frank MB, McCubbin VR, Reichlin M. The autoantibody response to Ro/SS-A in cutaneous lupus erythematosus. Arch Dermatol 1994;130:1262-8.
30. Catoggio LF, Skinner RP, Smith G y cols. Systemic lupus erythematosus in the elderly: clinical and serologic characteristics. J Rheumatol 1984;11:175-81.
31. Bonfa E, Elkon KB. Clinical and serological associations of the anti-ribosomal P protein antibody. Arthritis Rheum 1986;29:981-5.
32. Bonfa E, Golombek SJ, Kaufman LD y cols. Association between lupus psycosis and anti-ribosomal P protein antibodies. N Engl J Med 1987;317:265-71.
33. Sato T, Uchiumi T, Ozawa T y cols. Autoantibodies against ribosomal proteins found with high frequency in systemic lupus erythematosus patients with active disease. J Rheumatol 1991;18:1681-4.
34. Cuadrado MJ, Amengual O, Khamashta MA. Anticuerpos antifosfolípido. Rev Esp Reumatol 1996;23:389-95.
35. Exner T, Triplett DA, Taberner D, Machin SJ. Guideline for testing and revised criteria for lupus anticoagulants. SSC Subcommitee for the standarization of lupus anticoagulant. Thromb Haemost 1991;65:320-2.
36. Hugues GRV. The antiphospholipid syndrome: ten years on. Lancet 1993;342:341-4.
37. Harris EN. Annotation: antiphospholipid antibodies. Br J Haematol 1990;74:l-9.
38. Jablonska S, Blaszczyk M, Chorzelski TP, Jarzabek-Chorzelska M, Kumar V, Beutner EH. Clinical relevance of immunologic findings in scleroderma. Clin Dermatol 1992;10:407-21.
39. Kuwana M, Kaburaki J, Okano Y, Tojo T, Homma M. Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis. Arthritis Rheum 1994;37:75-83.
40. McCarty GA, Rice JR, Bembe ML, Barada FA. Anticentromere antibody: clinical correlations and association with favourable prognosis in patients with scleroderma variants. Arthritis Rheum 1983;26:1-7.
41. López-Longo FJ, Grau R, Moreno AC. Anticuerpos antisintetasas ARNt y antinucleolares. Rev Esp Reumatol 1996;23:384-8.
42. Yoshida S, Akizuki M, Mimori T, Yamagata H, Inada S, Homma M. The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases. A marker for a subset of polymyositis with interstitial pulmonary fibrosis. Arthritis Rheum 1983;26:604-11.
43. López-Longo FJ, González CM, Monteagudo I. Anticuerpos anticitoplasma de neutrúfilo (ANCA). Rev Esp Reumatol 1996;23:350-6.
44. Barrio J, Sendino R, Del Campo I y cols. Lesiones cutáneas en vasculitis granulomatosas ANCA positivas. Med Cutan Iberr Lat Am 1996;24:34-8.
45. Falk RJ, Jeunette JC. Antineutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotising and crescentic glomerulonephritis. N Engl J Med 1988;318:1651-7.
46. Jennette JC, Falk RJ. Antineutrophil cytoplasmic autoantibodies and associated diseases: a review. Am J Kidney Dis 1990;15:517-29.
47. Lüdemann G, Gross WL. Autoantibodies against cytoplasmic structures of neutrophil granulocytes in Wegener's granulomatosis. Clin Exp Immunol 1987;69:350-7.
48. Specks V. Wheatly CL, McDonald TJ, Rohrbach MS, De Remee RA. Anticytoplasmic autoantibodies in the diagnosis and follow-up of Wegener's granulomatosis. Mayo Clin Proc 1989;64:28-36.
49. Kallenberg CGM, Mulder AH, Tervaert JW. Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders. Am J Med 1992;93:675-82.
50. Jennette JC, Wilkman AS, Falk RJ. Antineutrophil cytoplasmic autoantibodies-associated glomerulonephritis and vasculitis. Am J Pathol 1989;135:921-30.
51. Hauschild S, Schmitt WH, Csernok E, Flesch BK, Rautmann A, Gross WL. ANCA in systemic vasculitides, collagen vascular diseases, rheumatic disorders and inflammatory bowel diseases. Adv Exp Med Biol 1993;336:245-51.